Therapeutic Approach to Alzheimer’s Disease: Current Treatments and New Perspectives
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic Approach to Alzheimer’s Disease: Current Treatments and New Perspectives
Authors
Keywords
-
Journal
Pharmaceutics
Volume 14, Issue 6, Pages 1117
Publisher
MDPI AG
Online
2022-05-25
DOI
10.3390/pharmaceutics14061117
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intranasal insulin modulates cerebrospinal fluid markers of neuroinflammation in mild cognitive impairment and Alzheimer’s disease: a randomized trial
- (2022) Derek Kellar et al. Scientific Reports
- Nanocarrier mediated drug delivery as an impeccable therapeutic approach against Alzheimer’s disease
- (2022) Rajeev Taliyan et al. JOURNAL OF CONTROLLED RELEASE
- Early-Onset Alzheimer’s Disease: What Is Missing in Research?
- (2021) Temitope Ayodele et al. Current Neurology and Neuroscience Reports
- Participation of Amyloid and Tau Protein in Post-Ischemic Neurodegeneration of the Hippocampus of a Nature Identical to Alzheimer's Disease
- (2021) Ryszard Pluta et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Serotonin 2 Receptors, Agomelatine, and Behavioral and Psychological Symptoms of Dementia in Alzheimer’s Disease
- (2021) Hui-Hua Li et al. BEHAVIOURAL NEUROLOGY
- Melatonin and Sleep Disturbances in Alzheimer’s Disease
- (2021) A. H. M. Safayet Ullah Prodhan et al. CNS & Neurological Disorders-Drug Targets
- Critical Appraisal of Amyloid Lowering Agents in AD
- (2021) Boris Decourt et al. Current Neurology and Neuroscience Reports
- Design of a patient‐ and investigator‐blind, randomized, placebo‐controlled study to evaluate efficacy, safety, and tolerability of bepranemab, UCB0107, in prodromal to mild Alzheimer’s disease: The TOGETHER Study, AH0003
- (2021) Matthew E Barton et al. Alzheimers & Dementia
- The impact of diabetes on cognitive impairment and its progression to dementia
- (2021) Abigail Dove et al. Alzheimers & Dementia
- Emerging roles of oxidative stress in brain aging and Alzheimer's disease
- (2021) Andra Ionescu-Tucker et al. NEUROBIOLOGY OF AGING
- Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease
- (2021) Stephen Salloway et al. JAMA Neurology
- Current Understanding of the Physiopathology, Diagnosis and Therapeutic Approach to Alzheimer’s Disease
- (2021) Victoria García-Morales et al. Biomedicines
- An update on the utility and safety of cholinesterase inhibitors for the treatment of Alzheimer’s disease
- (2020) Andrea Haake et al. Expert Opinion On Drug Safety
- Amyloid beta and diabetic pathology cooperatively stimulate cytokine expression in an Alzheimer’s mouse model
- (2020) Sitara B. Sankar et al. Journal of Neuroinflammation
- Dual-Sensitive Nanomicelles Enhancing Systemic Delivery of Therapeutically Active Antibodies Specifically into the Brain
- (2020) Jinbing Xie et al. ACS Nano
- Curcumin in Health and Diseases: Alzheimer’s Disease and Curcumin Analogues, Derivatives, and Hybrids
- (2020) Eirini Chainoglou et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Golgi-Cox impregnation combined with fluorescence staining of amyloid plaques reveals local spine loss in an Alzheimer mouse model
- (2020) Georgia-Ioanna Kartalou et al. JOURNAL OF NEUROSCIENCE METHODS
- Preventive and Therapeutic Strategies in Alzheimer's Disease: Focus on Oxidative Stress, Redox Metals, and Ferroptosis
- (2020) Germán Plascencia-Villa et al. ANTIOXIDANTS & REDOX SIGNALING
- Polyphenols as Potential Metal Chelation Compounds Against Alzheimer’s Disease
- (2020) Johant Lakey-Beitia et al. JOURNAL OF ALZHEIMERS DISEASE
- Safety, Tolerability, and Pharmacokinetics of Crenezumab in Patients with Mild-to-Moderate Alzheimer’s Disease Treated with Escalating Doses for up to 133 Weeks
- (2020) Heather Guthrie et al. JOURNAL OF ALZHEIMERS DISEASE
- Targeting nanoparticles to the brain by exploiting the blood–brain barrier impermeability to selectively label the brain endothelium
- (2020) Daniel Gonzalez-Carter et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Effects of a Recollection-Based Occupational Therapy Program of Alzheimer’s Disease: A Randomized Controlled Trial
- (2020) DeokJu Kim Occupational Therapy International
- Memantine, Donepezil, or Combination Therapy—What is the best therapy for Alzheimer’s Disease? A Network Meta‐Analysis
- (2020) Jiaxun Guo et al. Brain and Behavior
- Melatonin regulates Aβ production/clearance balance and Aβ neurotoxicity: A potential therapeutic molecule for Alzheimer’s disease
- (2020) Yuanming Li et al. BIOMEDICINE & PHARMACOTHERAPY
- New Insights Into Drug Discovery Targeting Tau Protein
- (2020) Yoshiyuki Soeda et al. Frontiers in Molecular Neuroscience
- Untangling the tau microtubule-binding region
- (2020) Jamie Toombs et al. BRAIN
- Review of Current Strategies for Delivering Alzheimer’s Disease Drugs across the Blood-Brain Barrier
- (2019) Ka Wong et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Implications of sleep disturbance and inflammation for Alzheimer's disease dementia
- (2019) Michael R Irwin et al. LANCET NEUROLOGY
- Effects of melatonin administration on mental health parameters, metabolic and genetic profiles in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial
- (2019) Azade Shabani et al. JOURNAL OF AFFECTIVE DISORDERS
- Preliminary Results of a Trial of Atabecestat in Preclinical Alzheimer’s Disease
- (2019) David Henley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Trial of Verubecestat for Prodromal Alzheimer’s Disease
- (2019) Michael F. Egan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Current and Future Treatments in Alzheimer's Disease
- (2019) Alireza Atri SEMINARS IN NEUROLOGY
- Safety and tolerability of donepezil 23 mg with or without intermediate dose titration in patients with Alzheimer’s disease taking donepezil 10 mg: a multicenter, randomized, open-label, parallel-design, three-arm, prospective trial
- (2019) Yun Jeong Hong et al. Alzheimers Research & Therapy
- Meta-Analysis of Randomized Controlled Trials on the Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer’s Disease
- (2019) Dan-Dan Li et al. Frontiers in Neuroscience
- γ-AApeptides as a New Strategy for Therapeutic Development
- (2019) Alekhya Nimmagadda et al. CURRENT MEDICINAL CHEMISTRY
- Regulation of neuronal microtubule dynamics by tau: Implications for tauopathies
- (2019) Anuradha Venkatramani et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Prevention and Treatment of Alzheimer’s Disease: Biological Mechanisms of Exercise
- (2019) Hugo McGurran et al. JOURNAL OF ALZHEIMERS DISEASE
- Lithium as a Treatment for Alzheimer’s Disease: The Systems Pharmacology Perspective
- (2019) Harald Hampel et al. JOURNAL OF ALZHEIMERS DISEASE
- Mediterranean diet: The role of long-chain ω-3 fatty acids in fish; polyphenols in fruits, vegetables, cereals, coffee, tea, cacao and wine; probiotics and vitamins in prevention of stroke, age-related cognitive decline, and Alzheimer disease
- (2019) G.C. Román et al. REVUE NEUROLOGIQUE
- Cortical tau deposition follows patterns of entorhinal functional connectivity in aging
- (2019) Jenna N Adams et al. eLife
- Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
- (2019) Justin M. Long et al. CELL
- Investigational BACE inhibitors for the treatment of Alzheimer’s disease
- (2019) Bruno P. Imbimbo et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Therapeutic strategies and nano-drug delivery applications in management of ageing Alzheimer’s disease
- (2018) Govindarajan Karthivashan et al. DRUG DELIVERY
- An Overview on the Clinical Development of Tau-Based Therapeutics
- (2018) Miguel Medina INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Does Music Therapy Improve Anxiety and Depression in Alzheimer's Patients?
- (2018) José Enrique de la Rubia Ortí et al. JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE
- Alzheimer's disease research: the future of BACE inhibitors
- (2018) Talha Burki LANCET
- Exercise decreases BACE and APP levels in the hippocampus of a rat model of Alzheimer's disease
- (2018) Karim A. Alkadhi et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Metal Protein-Attenuating Compound for PET Neuroimaging: Synthesis and Preclinical Evaluation of [11C]PBT2
- (2018) Hema S. Krishnan et al. MOLECULAR PHARMACEUTICS
- Tau-targeting therapies for Alzheimer disease
- (2018) Erin E. Congdon et al. Nature Reviews Neurology
- Una revisión de los avances en la terapéutica de la enfermedad de Alzheimer: estrategia frente a la proteína β-amiloide
- (2018) J. Folch et al. NEUROLOGIA
- Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease
- (2018) Lawrence S. Honig et al. NEW ENGLAND JOURNAL OF MEDICINE
- Protective roles of melatonin against the amyloid-dependent development of Alzheimer’s disease: A critical review
- (2018) Bruno Vincent PHARMACOLOGICAL RESEARCH
- Safety, tolerability and immunogenicity of an active anti-Aβ40 vaccine (ABvac40) in patients with Alzheimer’s disease: a randomised, double-blind, placebo-controlled, phase I trial
- (2018) Ana-María Lacosta et al. Alzheimers Research & Therapy
- An evaluation of memantine ER + donepezil for the treatment of Alzheimer’s disease
- (2018) Amanda Calhoun et al. EXPERT OPINION ON PHARMACOTHERAPY
- Alzheimer's Disease, time to turn the tide
- (2018) Stefano L. Sensi Aging-US
- BACE inhibitors in clinical development for the treatment of Alzheimer’s disease
- (2018) Francesco Panza et al. Expert Review of Neurotherapeutics
- The Multidisciplinary Approach to Alzheimer's Disease and Dementia. A Narrative Review of Non-Pharmacological Treatment
- (2018) Chiara Zucchella et al. Frontiers in Neurology
- Synthesis and biological evaluation of deferiprone-resveratrol hybrids as antioxidants, Aβ 1–42 aggregation inhibitors and metal-chelating agents for Alzheimer's disease
- (2017) Ping Xu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Efficacy and Safety of Plasma Exchange with 5% Albumin to Modify Cerebrospinal Fluid and Plasma Amyloid-β Concentrations and Cognition Outcomes in Alzheimer’s Disease Patients: A Multicenter, Randomized, Controlled Clinical Trial
- (2017) Mercè Boada et al. JOURNAL OF ALZHEIMERS DISEASE
- Recent Progress in Alzheimer’s Disease Research, Part 3: Diagnosis and Treatment
- (2017) Francis T. Hane et al. JOURNAL OF ALZHEIMERS DISEASE
- Treadmill Exercise Exerts Neuroprotection and Regulates Microglial Polarization and Oxidative Stress in a Streptozotocin-Induced Rat Model of Sporadic Alzheimer’s Disease
- (2017) Yujiao Lu et al. JOURNAL OF ALZHEIMERS DISEASE
- Efficacy and Safety of Donepezil in Chinese Patients with Severe Alzheimer’s Disease: A Randomized Controlled Trial
- (2017) Jianping Jia et al. JOURNAL OF ALZHEIMERS DISEASE
- Increased Brain Glucose Uptake After 12 Weeks of Aerobic High-Intensity Interval Training in Young and Older Adults
- (2017) Matthew M Robinson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Is Alzheimer's Prevention Possible Today?
- (2017) Richard Isaacson JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Cerebrovascular function in presymptomatic and symptomatic individuals with hereditary cerebral amyloid angiopathy: a case-control study
- (2017) Anna M van Opstal et al. LANCET NEUROLOGY
- Tacrine: In vivo veritas
- (2017) Bevyn Jarrott PHARMACOLOGICAL RESEARCH
- A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
- (2017) Susanne Ostrowitzki et al. Alzheimers Research & Therapy
- Nutritional interventions for Alzheimer's prevention: a clinical precision medicine approach
- (2016) Matthew W. Schelke et al. Annals of the New York Academy of Sciences
- On the early diagnosis of Alzheimer's Disease from multimodal signals: A survey
- (2016) Ane Alberdi et al. ARTIFICIAL INTELLIGENCE IN MEDICINE
- Improved brain expression of anti-amyloid β scFv by complexation of mRNA including a secretion sequence with PEG-based block catiomer
- (2016) Federico Perche et al. Current Alzheimer Research
- Pharmacological, toxicological and neuronal localization assessment of galantamine/chitosan complex nanoparticles in rats: future potential contribution in Alzheimer’s disease management
- (2016) Amira S. Hanafy et al. DRUG DELIVERY
- Intranasal delivery of nanoparticle encapsulated tarenflurbil: A potential brain targeting strategy for Alzheimer's disease
- (2016) Eameema Muntimadugu et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Cost-effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO-AD trial)
- (2016) Martin Knapp et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Isothiocyanates Are Promising Compounds against Oxidative Stress, Neuroinflammation and Cell Death that May Benefit Neurodegeneration in Parkinson’s Disease
- (2016) Giulia Sita et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Efficacy and Safety of Sustained Release Donepezil High Dose versus Immediate Release Donepezil Standard Dose in Japanese Patients with Severe Alzheimer’s Disease: A Randomized, Double-Blind Trial
- (2016) Akira Homma et al. JOURNAL OF ALZHEIMERS DISEASE
- Inflammation, Antiinflammatory Agents, and Alzheimer’s Disease: The Last 22 Years
- (2016) Patrick L. McGeer et al. JOURNAL OF ALZHEIMERS DISEASE
- Ceria-containing uncoated and coated hydroxyapatite-based galantamine nanocomposites for formidable treatment of Alzheimer's disease in ovariectomized albino-rat model
- (2016) Sanaa M.R. Wahba et al. Materials Science & Engineering C-Materials for Biological Applications
- Progressive Neuronal Pathology and Synaptic Loss Induced by Prediabetes and Type 2 Diabetes in a Mouse Model of Alzheimer’s Disease
- (2016) Juan Jose Ramos-Rodriguez et al. MOLECULAR NEUROBIOLOGY
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2016) Jeff Sevigny et al. NATURE
- Mechanisms linking circadian clocks, sleep, and neurodegeneration
- (2016) Erik S. Musiek et al. SCIENCE
- Aging process, cognitive decline and Alzheimer`s disease: can strength training modulate these responses?
- (2015) Eduardo Portugal et al. CNS & Neurological Disorders-Drug Targets
- Amyloid-Beta Protein Clearance and Degradation (ABCD) Pathways and their Role in Alzheimer’s Disease
- (2015) Robert Baranello et al. Current Alzheimer Research
- Galantamine-loaded solid–lipid nanoparticles for enhanced brain delivery: preparation, characterization,in vitroandin vivoevaluations
- (2015) Shubham Misra et al. DRUG DELIVERY
- Removing endogenous tau does not prevent tau propagation yet reduces its neurotoxicity
- (2015) S. Wegmann et al. EMBO JOURNAL
- Analysis of in vivo turnover of tau in a mouse model of tauopathy
- (2015) Kaoru Yamada et al. Molecular Neurodegeneration
- Immunotherapeutic Approaches for Alzheimer’s Disease
- (2015) Thomas Wisniewski et al. NEURON
- Targeting Prodromal Alzheimer Disease With Avagacestat
- (2015) Vladimir Coric et al. JAMA Neurology
- The acute hepatotoxicity of tacrine explained by 1H NMR based metabolomic profiling
- (2015) Yan-Hong Lou et al. Toxicology Research
- Physical Exercise in MCI Elderly Promotes Reduction of Pro-Inflammatory Cytokines and Improvements on Cognition and BDNF Peripheral Levels
- (2014) Carla Nascimento et al. Current Alzheimer Research
- Estimating the burden of early onset dementia; systematic review of disease prevalence
- (2014) M. A. Lambert et al. EUROPEAN JOURNAL OF NEUROLOGY
- Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014
- (2014) L. S. Schneider et al. JOURNAL OF INTERNAL MEDICINE
- Preventive Effects of Ramelteon on Delirium
- (2014) Kotaro Hatta et al. JAMA Psychiatry
- Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer’s disease: a 6-month, randomized, placebo-controlled, multicenter trial
- (2014) Moshe Laudon et al. Clinical Interventions in Aging
- The global prevalence of dementia: A systematic review and metaanalysis
- (2013) Martin Prince et al. Alzheimers & Dementia
- Beneficial effects of physical exercise on neuroplasticity and cognition
- (2013) Kirsten Hötting et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease
- (2013) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- EHT0202 in Alzheimers Disease: A 3-Month, Randomized, Placebo- Controlled, Double-Blind Study
- (2012) B. Vellas et al. Current Alzheimer Research
- Current and future treatments for Alzheimer’s disease
- (2012) Konstantina G. Yiannopoulou et al. Therapeutic Advances in Neurological Disorders
- Galantamine and behavior in Alzheimer disease: analysis of four trials
- (2011) S. Kavanagh et al. ACTA NEUROLOGICA SCANDINAVICA
- Physical therapy intervention (PTI) increases plasma brain-derived neurotrophic factor (BDNF) levels in non-frail and pre-frail elderly women
- (2011) F.M. Coelho et al. ARCHIVES OF GERONTOLOGY AND GERIATRICS
- Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment
- (2011) Suzanne Craft ARCHIVES OF NEUROLOGY
- Use of memantine for the treatment of dementia
- (2011) Daphne Lo et al. Expert Review of Neurotherapeutics
- Alzheimer’s disease: pathological mechanisms and the beneficial role of melatonin
- (2011) Sergio A. Rosales-Corral et al. JOURNAL OF PINEAL RESEARCH
- Physical Training Improves Motor Performance in People with Dementia: A Randomized Controlled Trial
- (2011) Klaus Hauer et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issues
- (2011) Davide Brambilla et al. Nanomedicine-Nanotechnology Biology and Medicine
- A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease
- (2011) S. Salloway et al. NEUROLOGY
- The Pharmacoeconomics of Cognitive Enhancers in Moderate to Severe Alzheimerʼs Disease
- (2010) Jaclyn Cappell et al. CNS DRUGS
- SB-742457 and donepezil in Alzheimer disease: a randomized, placebo-controlled study
- (2010) Gareth Maher-Edwards et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Treadmill exercise represses neuronal cell death in an aged transgenic mouse model of Alzheimer's disease
- (2010) Hyun-Sub Um et al. NEUROSCIENCE RESEARCH
- Galantamine-ER for the treatment of mild-to-moderate Alzheimer’s disease
- (2010) Ben Seltzer Clinical Interventions in Aging
- Donepezil Treatment of Patients with Severe Alzheimer’s Disease in a Japanese Population: Results from a 24-Week, Double-Blind, Placebo-Controlled, Randomized Trial
- (2008) Akira Homma et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Donepezil: potential neuroprotective and disease-modifying effects
- (2008) Sandra A Jacobson et al. Expert Opinion on Drug Metabolism & Toxicology
- Melatonin and Bright-Light Treatment for RestâActivity Disruption in Institutionalized Patients with Alzheimer's Disease
- (2008) Glenna A. Dowling et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started